[HTML][HTML] 超声检查指标联合预测甲状腺乳头状癌颈部中央区淋巴结转移的价值研究
张晓梅， 康燕飞， 桑田， 成静， 李巧莉， 曹玉文， 马金梅… - 中国全科医学, 2022 - chinagp.net
背景常规超声检查指标单独诊断甲状腺乳头状癌(PTC) 颈部中央区淋巴结转移(CLNM)
的灵敏度较低, 而淋巴结转移(LNM) 与否可影响患者的诊疗方案. 目的探讨超声检查指标联合 …
的灵敏度较低, 而淋巴结转移(LNM) 与否可影响患者的诊疗方案. 目的探讨超声检查指标联合 …
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients
H Zhao, C Liu, Y Lu, SZ Liu, P Yeerkenbieke, Y Cao… - Oral Oncology, 2024 - Elsevier
Object: Previous studies suggest BRAF V600E mutation is a marker for poor prognosis in
papillary thyroid cancer, however, its ability to further risk stratify papillary thyroid …
papillary thyroid cancer, however, its ability to further risk stratify papillary thyroid …
A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma
BD Chen, Z Zhang, KK Wang, MY Shang… - Cancer management …, 2019 - Taylor & Francis
Background: Prophylactic central lymph node dissection (CLND) in papillary thyroid
microcarcinoma (PTMC) patients without clinical evidence of central lymph node metastasis …
microcarcinoma (PTMC) patients without clinical evidence of central lymph node metastasis …
An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy
H Zhao, CH Liu, Y Cao, LY Zhang, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Background Radioiodine (RAI) therapy plays a vital role in the postoperative treatment of
differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However …
differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However …
[PDF][PDF] cN0 期甲状腺微小乳头状癌侧颈淋巴结转移危险因素分析
沈文亮， 吕晶， 黑虎， 秦建武 - 中国普通外科杂志, 2019 - zpwz.net
摘要目的: 探讨甲状腺微小乳头状癌(PTMC) 患者侧颈区淋巴结转移的危险因素. 方法:
回顾性分析462 例临床淋巴结阴性(cN0) 的PTMC 患者的术前彩超及临床病理资料, 应用χ2 …
回顾性分析462 例临床淋巴结阴性(cN0) 的PTMC 患者的术前彩超及临床病理资料, 应用χ2 …
Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
D Zhu, X Wu, L Zhang, Z Chen - Alternative Therapies in …, 2023 - search.ebscohost.com
Objective• The objective of this study was to construct and validate a nomogram for
preoperatively identifying central lymph node metastasis (CLNM) in patients with papillary …
preoperatively identifying central lymph node metastasis (CLNM) in patients with papillary …
Prediction of central compartment nodal metastases in papillary thyroid cancer using TI-RADS score, blood flow, and multifocality
JR Yang, Y Song, SJ Chang, LL Shi - Acta Radiologica, 2022 - journals.sagepub.com
Background The relationship between the American College of Radiology (ACR) Thyroid
Imaging Reporting and Data System (TI-RADS) and the risk of lymph node metastases in …
Imaging Reporting and Data System (TI-RADS) and the risk of lymph node metastases in …
Predictive Value of Combined Use of Ultrasonographic Indicators for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
X ZHANG, Y KANG, T SANG, J CHENG, Q LI… - Chinese General …, 2022 - chinagp.net
<p class="MsoNormal"> <span>Predictive Value of Combined Use of Ultrasonographic
Indicators for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma</span> Home …
Indicators for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma</span> Home …
[PDF][PDF] 活化的NK 细胞与分化型甲状腺癌术后复发关系的TCGA 数据库分析
李红强， 董晔尧， 柳桢， 王龙龙， 殷德涛 - 中国普通外科杂志, 2019 - zpwz.net
摘要目的: 探讨免疫细胞浸润与分化型甲状腺癌术后复发之间的关系. 方法: 从TCGA
数据库中下载507 例分化型甲状腺癌患者的临床数据, 运用反卷积算法估算22 …
数据库中下载507 例分化型甲状腺癌患者的临床数据, 运用反卷积算法估算22 …
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis
H Zhao, CH Liu, Y Cao, LY Zhang, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Background The prognostic factors for differentiated thyroid cancer (DTC) patients with
pulmonary metastases (PM) remain scantly identified and analyzed. Therefore, this …
pulmonary metastases (PM) remain scantly identified and analyzed. Therefore, this …